These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 12526358)

  • 21. [Study on using colloidal gold immuno-dot assay to detect special antibody of hemorrhagic fever renal syndrome].
    Chu F; Ji Q; Yan RM
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2001 Jul; 21(7):504-6. PubMed ID: 12575393
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical study and immunological observation on potenlini treatment of epidemic hemorrhage fever].
    Xu XT; Jing PT; Wang CL
    Zhonghua Nei Ke Za Zhi; 1990 Dec; 29(12):739-41, 766. PubMed ID: 1982648
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Use of recombinant interleukin-2 in hemorrhagic fever with renal syndrome].
    Shutov AM; Savinova GA; Kiselev LI; Smirnov MN; Iudintseva EV
    Klin Med (Mosk); 2002; 80(4):54-7. PubMed ID: 12043267
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [A 5-year follow-up study of antiviral effect of interferon in patients with chronic hepatitis C].
    Jiang Y; Yao J; Peng W
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1998 Dec; 12(4):373-6. PubMed ID: 12526359
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lymphoblastoid interferon alfa-n1 improves the long-term response to a 6-month course of treatment in chronic hepatitis C compared with recombinant interferon alfa-2b: results of an international randomized controlled trial. Clinical Advisory Group for the Hepatitis C Comparative Study.
    Farrell GC; Bacon BR; Goldin RD
    Hepatology; 1998 Apr; 27(4):1121-7. PubMed ID: 9537453
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phase II study of interferon-gamma versus interleukin-2 and interferon-alpha 2b in metastatic renal cell carcinoma.
    Lümmen G; Goepel M; Möllhoff S; Hinke A; Otto T; Rübben H
    J Urol; 1996 Feb; 155(2):455-8. PubMed ID: 8558634
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activity of combination therapy with interferon alfa-2b plus ribavirin in chronic hepatitis C patients co-infected with HIV.
    Dieterich DT; Purow JM; Rajapaksa R
    Semin Liver Dis; 1999; 19 Suppl 1():87-94. PubMed ID: 10349696
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [3 cases of hemorrhagic fever with renal syndrome morbidity].
    Nafeev AA
    Klin Med (Mosk); 2008; 86(4):70-1. PubMed ID: 18494292
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sustained virologic response is associated with improved health-related quality of life in relapsed chronic hepatitis C patients.
    Neary MP; Cort S; Bayliss MS; Ware JE
    Semin Liver Dis; 1999; 19 Suppl 1():77-85. PubMed ID: 10349695
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term prognosis of chronic hepatitis C after treatment with interferon alpha 2b and characterization of incomplete responders.
    Hakozaki Y; Shirahama T; Katou M; Nakagawa K; Oba K; Yoshii O; Matsumoto T; Kuwabara N; Mitamura K
    Am J Gastroenterol; 1996 Oct; 91(10):2144-9. PubMed ID: 8855738
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thrombotic microangiopathy associated with interferon therapy for patients with chronic myelogenous leukemia: coincidence or true side effect?
    Ravandi-Kashani F; Cortes J; Talpaz M; Kantarjian HM
    Cancer; 1999 Jun; 85(12):2583-8. PubMed ID: 10375106
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical study of prophylactic therapy of interferon on postoperative renal cell carcinoma].
    Yasumoto R; Asakawa M; Hayahara N; Maekawa T; Wada S; Kishimoto T; Maekawa M; Morikawa Y; Kawakita J; Umeda M
    Hinyokika Kiyo; 1992 Mar; 38(3):267-75. PubMed ID: 1523980
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of recombinant alpha-interferon on pharmacokinetics, biodistribution, toxicity, and efficacy of 131I-labeled monoclonal antibody CC49 in breast cancer: a phase II trial.
    Macey DJ; Grant EJ; Kasi L; Rosenblum MG; Zhang HZ; Katz RL; Rieger PT; LeBherz D; South M; Greiner JW; Schlom J; Podoloff DA; Murray JL
    Clin Cancer Res; 1997 Sep; 3(9):1547-55. PubMed ID: 9815842
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Application of ribavirin in patients having hemorrhagic fever with renal syndrome].
    Zivković M; Todorović Z; Canović P; Mijanović Z
    Med Pregl; 2009; 62(1-2):63-7. PubMed ID: 19514603
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Interferon alpha-2b in the complex therapy of patients with pulmonary tuberculosis concurrent with bronchoobstructive syndrome].
    Zhukova EM; Krasnov VA; Petrenko TI; Romanov VV
    Tuberk Biolezni Legkih; 2009; (12):58-61. PubMed ID: 20095375
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recombinant alpha-2b-interferon dynamic test as a potential tool in predicting disease status during second look in ovarian cancer. A preliminary report.
    Scambia G; Panici PB; Baiocchi G; Gallo A; Laurelli G; Iacobelli S; Mancuso S
    Cancer; 1991 Dec; 68(12):2582-5. PubMed ID: 1933806
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recombinant alpha-2b-interferon enhances the circulating levels of a 90-kilodalton (K) tumor-associated antigen in patients with gynecologic and breast malignancies.
    Scambia G; Panici PB; Iacobelli S; Baiocchi G; Battaglia F; Perrone L; Sonsini C; Ferrandina G; Natoli C; Mancuso S
    Cancer; 1990 Mar; 65(6):1325-8. PubMed ID: 2306681
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recombinant interferon alpha (rIFN alpha-2b) may retard progression of early primary myelofibrosis.
    Silver RT; Vandris K
    Leukemia; 2009 Jul; 23(7):1366-9. PubMed ID: 19440212
    [No Abstract]   [Full Text] [Related]  

  • 39. [Interferon in patients with hemorrhagic fever with renal syndrome].
    Murzabaeva RT
    Zh Mikrobiol Epidemiol Immunobiol; 2002; (5):74-6. PubMed ID: 12525009
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hemorrhagic fever with renal syndrome: treatment with recombinant alpha interferon.
    Gui XE; Ho M; Cohen MS; Wang QL; Huang HP; Xie QX
    J Infect Dis; 1987 May; 155(5):1047-51. PubMed ID: 2881968
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.